Pharmacogenomics and public health.
作者信息
Veenstra D, Burke W
机构信息
Department of Pharmacy, Center for Genomics and Healthcare Equality, University of Washington, Seattle, Wash, USA.
出版信息
Public Health Genomics. 2009;12(3):131-3. doi: 10.1159/000189624. Epub 2009 Feb 10.
Abstract
摘要
相似文献
1
Pharmacogenomics and public health.药物基因组学与公共卫生。
Public Health Genomics. 2009;12(3):131-3. doi: 10.1159/000189624. Epub 2009 Feb 10.
2
Pharmacogenomics and public health: implementing 'populationalized' medicine.药物基因组学与公共卫生：实施“群体化”医学。
Pharmacogenomics. 2012 May;13(7):803-13. doi: 10.2217/pgs.12.52.
3
Public health pharmacogenomics.公共卫生药物基因组学
Public Health Genomics. 2014;17(5-6):245-7. doi: 10.1159/000366459. Epub 2014 Oct 17.
4
Population pharmacogenomics: impact on public health and drug development.群体药物基因组学：对公共卫生和药物研发的影响
Pharmacogenomics. 2018 Jan;19(1):3-6. doi: 10.2217/pgs-2017-0166. Epub 2017 Dec 1.
5
Role of pharmacogenetics in public health and clinical health care: a SWOT analysis.药物遗传学在公共卫生与临床医疗保健中的作用：一项SWOT分析。
Eur J Hum Genet. 2016 Dec;24(12):1651-1657. doi: 10.1038/ejhg.2016.114. Epub 2016 Aug 31.
6
Pharmacogenetics and pharmacogenomics: recent developments, their clinical relevance and some ethical, social, and legal implications.药物遗传学与药物基因组学：最新进展、临床相关性及一些伦理、社会和法律问题
J Mol Med (Berl). 2003 Mar;81(3):135-40. doi: 10.1007/s00109-002-0415-6.
7
Clinical trials in pharmacogenetics and pharmacogenomics: methods and applications.药物遗传学和药物基因组学中的临床试验：方法与应用
Am J Health Syst Pharm. 2000 May 1;57(9):887-98; quiz 899-901. doi: 10.1093/ajhp/57.9.887.
8
ACCE, pharmacogenomics, and stopping clinical trials: time to extend the CONSORT statement?ACCE、药物基因组学与临床试验终止：是时候扩展CONSORT声明了吗？
Am J Bioeth. 2011 Mar;11(3):11-3. doi: 10.1080/15265161.2010.546477.
9
Pharmacogenomics guidelines: Current status and future development.药物基因组学指南：现状与未来发展。
Clin Exp Pharmacol Physiol. 2019 Aug;46(8):689-693. doi: 10.1111/1440-1681.13097. Epub 2019 May 16.
10
Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.肿瘤治疗性抗体开发中的药物遗传学和药物基因组学
Biotechniques. 2005 Oct;39(10 Suppl):S565-8. doi: 10.2144/000112043.
引用本文的文献
1
Generic Cost-Effectiveness Models: A Proof of Concept of a Tool for Informed Decision-Making for Public Health Precision Medicine.通用成本效益模型：公共卫生精准医学明智决策工具的概念验证
Public Health Genomics. 2018;21(5-6):217-227. doi: 10.1159/000500725. Epub 2019 Jun 12.
2
Is individualized medicine more cost-effective? A systematic review.个性化医疗是否更具成本效益？一项系统评价。
Pharmacoeconomics. 2014 May;32(5):443-55. doi: 10.1007/s40273-014-0143-0.
3
End of the Beginning and Public Health Pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine.开端的结束与公共卫生药物基因组学：“模式2”和精准预防、预测、个体化、参与式、预防性（P5）医学中的知识
Curr Pharmacogenomics Person Med. 2012 Jan 1;10(1):1-6. doi: 10.2174/1875692111201010001.
本文引用的文献
1
Researchers' perceptions of the ethical implications of pharmacogenomics research with children.研究人员对儿童药物基因组学研究伦理影响的看法。
Public Health Genomics. 2009;12(3):191-201. doi: 10.1159/000189633. Epub 2009 Feb 10.
2
Will pharmacogenomics disrupt the U.S. health care system? No.药物基因组学会扰乱美国的医疗保健系统吗？不会。
Public Health Genomics. 2009;12(3):185-90. doi: 10.1159/000189632. Epub 2009 Feb 10.
3
The disruptive nature of personalized medicine technologies: implications for the health care system.个性化医疗技术的颠覆性本质：对医疗保健系统的影响。
Public Health Genomics. 2009;12(3):180-4. doi: 10.1159/000189631. Epub 2009 Feb 10.
4
Pharmacogenomics and the challenge of health disparities.药物基因组学与健康差异挑战
Public Health Genomics. 2009;12(3):170-9. doi: 10.1159/000189630. Epub 2009 Feb 10.
5
Assessing patient readiness for the clinical adoption of personalized medicine.评估患者对临床采用个性化医疗的准备情况。
Public Health Genomics. 2009;12(3):163-9. doi: 10.1159/000189629. Epub 2009 Feb 10.
6
The potential of a placebo/nocebo effect in pharmacogenetics.药物遗传学中安慰剂/反安慰剂效应的潜力。
Public Health Genomics. 2009;12(3):158-62. doi: 10.1159/000189628. Epub 2009 Feb 10.
7
Pharmacogenomics, evidence, and the role of payers.药物基因组学、证据及支付方的作用。
Public Health Genomics. 2009;12(3):149-57. doi: 10.1159/000189627. Epub 2009 Feb 10.
8
Trends in pharmacogenomic epidemiology: 2001-2007.药物基因组流行病学趋势：2001 - 2007年
Public Health Genomics. 2009;12(3):142-8. doi: 10.1159/000189626. Epub 2009 Feb 10.
9
Pharmacogenetics in Europe: barriers and opportunities.欧洲的药物遗传学：障碍与机遇
Public Health Genomics. 2009;12(3):134-41. doi: 10.1159/000189625. Epub 2009 Feb 10.
10
Warfarin pharmacogenetics.华法林药物遗传学
Pharmacotherapy. 2008 Sep;28(9):1084-97. doi: 10.1592/phco.28.9.1084.
Zotero 插件